Skip to main content

Mountcastle David's Form 4 filing

Privia Health Group, Inc. (PRVA) · filed Jul 19, 2022

Accession no.
0001759655-22-000099
Filed
Jul 19, 2022
Trade date
Jul 15-18, 2022
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $972.0K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Mountcastle DavidCIK 0001858396Officer (EVP & Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 15, 2022Common Stock, par value $0.01 per shareMOption exerciseAcquired+3,429$2.00+$6,85896,080Direct
Jul 15, 2022Common Stock, par value $0.01 per shareSSaleDisposed−3,429$35.00F2−$120,01592,651Direct
Jul 18, 2022Common Stock, par value $0.01 per shareMOption exerciseAcquired+51,756$2.00+$103,512144,407Direct
Jul 18, 2022Common Stock, par value $0.01 per shareSSaleDisposed−24,990$34.06F3−$851,159.4119,417Direct
Jul 18, 2022Common Stock, par value $0.01 per shareSSaleDisposed−25$35.00−$875119,392Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jul 15, 2022Common StockMOption exerciseDisposed−3,429$0.00$093,568Direct
Jul 18, 2022Common StockMOption exerciseDisposed−51,756$0.00$041,812Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.00 to $35.015 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Referenced by the price of 1 transaction in Table I.

F3

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.81 to $34.80 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)